New drug tested for debilitating blood disorder
Disease control
Recruiting now
This early-stage study is testing the safety of an oral drug called panobinostat in adults with sickle cell disease who haven't responded well to standard treatment. Researchers want to find the highest dose patients can tolerate without severe side effects. The study will also c…
Phase: PHASE1 • Sponsor: Abdullah Kutlar • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC